Focused Orticumab Research for Treating Inflammation in Coronary Arteries

NCT06927739 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndromes
Coronary Arterial Disease (CAD)
Inflammation
Heart Disease
Myocardial Infarct
Atherosclerotic Coronary Vascular Disease

Interventions

DRUG: Orticumab
DRUG: Placebo

Sponsor

Abcentra